Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amdoxovir Extension Study in HIV-1
NCT01738555Phase 2Withdrawn
- Sponsor
- RFS Pharma
- Start
- Apr 2013
- Primary completion
- Aug 2014
- Modality
- Metabolically Activated Prodrugs
01
Overview
A Phase 2 trial of amdoxovir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by RFS Pharma. Planned start Apr 2013; status: withdrawn.
02
Drugs
amdoxovir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01738555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01738555.